Very recently, in relation to the COVID-19 pandemic, HSA and MYO have already been cited as proteins of major interest, either to estimate the mortality risk (HSA)77 or for monitoring patients undergoing treatments like hemodialysis or who are diagnosed with the complication rhabdomyolysis (MYO)33,78. Here, ALB is linked to rhabdomyolysis.